Natural killer T cells: drivers or passengers in preventing human disease? (Q51828144)

13 April 2018

http://europepmc.org/abstract/MED/25103356

title

Natural killer T cells: drivers or passengers in preventing human disease? (English)

1 reference

13 April 2018

http://europepmc.org/abstract/MED/25103356

author name string

Stuart P Berzins

series ordinal

1

1 reference

13 April 2018

http://europepmc.org/abstract/MED/25103356

David S Ritchie

series ordinal

2

1 reference

13 April 2018

http://europepmc.org/abstract/MED/25103356

publication date

8 August 2014

1 reference

13 April 2018

http://europepmc.org/abstract/MED/25103356

published in

Nature Reviews Immunology

1 reference

13 April 2018

http://europepmc.org/abstract/MED/25103356

volume

14

1 reference

13 April 2018

http://europepmc.org/abstract/MED/25103356

issue

9

1 reference

13 April 2018

http://europepmc.org/abstract/MED/25103356

page(s)

640-646

1 reference

13 April 2018

http://europepmc.org/abstract/MED/25103356

cites work

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Biology of CD1- and MR1-restricted T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Presumed guilty: natural killer T cell defects and human disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

NKT-cell-based immunotherapies in clinical trials.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

NKT cells: what's in a name?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Raising the NKT cell family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Recognition of CD1d-restricted antigens by natural killer T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

New ways to turn on NKT cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Natural Killer T cell obsession with self-antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Antigen-dependent versus -independent activation of invariant NKT cells during infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Differential antitumor immunity mediated by NKT cell subsets in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Distinct functional lineages of human V(alpha)24 natural killer T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Targeting natural killer cells and natural killer T cells in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Regulation of type 1 diabetes by NKT cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Clinical application of NKT cell biology in type I (autoimmune) diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Immune cell crosstalk in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

The many paths to asthma: phenotype shaped by innate and adaptive immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Natural killer T cells are important in the pathogenesis of asthma: the many pathways to asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

The role of NKT cells in tumor immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Differential tumor surveillance by natural killer (NK) and NKT cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Type I natural killer T cells suppress tumors caused by p53 loss in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Invariant NKT Cell Reconstitution in Pediatric Leukemia Patients Given HLA-Haploidentical Stem Cell Transplantation Defines Distinct CD4 + and CD4 − Subset Dynamics and Correlates with Remission State

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

NKT cells as an ideal anti-tumor immunotherapeutic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Congenic Analysis of the NKT Cell Control Gene Nkt2 Implicates the Peroxisomal Protein Pxmp4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Natural killer T cells and autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Natural killer T cells in the lungs of patients with asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Natural killer T cells in bronchial biopsies from human allergen challenge model of allergic asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Invariant natural killer T cells and asthma: Immunologic reality or methodologic artifact?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Limited correlation between human thymus and blood NKT?cell content revealed by an ontogeny study of paired tissue samples

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

The in vivo response of invariant natural killer T cells to glycolipid antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Synthetic iNKT cell-agonists as vaccine adjuvants--finding the balance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

A prescription for human immunology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Mucosal-associated invariant T cells: unconventional development and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Lower TCR repertoire diversity in Traj18-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V alpha 24+ NKT cell-mediated cytotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

The effect of radiotherapy on NKT cells in patients with advanced head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

The peripheral blood Valpha24+ NKT cell numbers decrease in patients with haematopoietic malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Immunomodulatory drugs Revlimid (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabetaTCR+CDR-CD8- thymocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Clinical application of NKT cell assays to the prediction of type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

High frequency of valpha24(+) vbeta11(+) T-cells observed in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with Type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Requirement for IL-13 independently of IL-4 in experimental asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

To respond or not to respond: T cells in allergic asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Natural killer T cells regulate the development of asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

Control points in NKT-cell development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI3725

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25103356

12 December 2020

inferred from PubMed ID database lookup

CD1-restricted T cells and tumor immunity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25103356

12 December 2020

inferred from PubMed ID database lookup

Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25103356

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRI3725

1 reference

13 April 2018

http://europepmc.org/abstract/MED/25103356

Fatcat ID

release_exjuxfvjdvalli43cbrotfdghm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/exjuxfvjdvalli43cbrotfdghm

24 November 2022

mapped directly with Wikidata item

1 reference

13 April 2018